A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
Clinical trial NCT02750761 · COMPLETED
Trial details
- NCT number
- NCT02750761
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-02
- Primary completion
- 2018-12-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.